Global Anti-obesity Medication Market Trends Analysis Report 2024-2030: Social Media Influences and Strategic Partnerships, Mergers, Acquisitions, and Collaborations Shaping the Landscape
April 11, 2024 11:14 ET
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-obesity Medication Market Size, Share & Trends Analysis Report" report has been added to ResearchAndMarkets.com's offering.The global...
Anti-Obesity Drug Market to Witness Robust Growth Through 2028 Amid Rising Global Obesity Concerns
December 20, 2023 10:38 ET
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Anti-obesity Drug Market Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering.The anti-obesity drug market is...
Diet Doc Patients Thought to Lose More Weight Than Contrave or Belviq Patients Without Dangerous Prescription Drug Side Effects
January 23, 2015 07:00 ET
|
Diet Doc Weight Loss
NEW YORK, Jan. 23, 2015 (GLOBE NEWSWIRE) -- Internet reports claiming that the Endocrine Society is now recommending prescription drugs to accompany diet plans for obese patients offer two drug...
Diet Doc Announces Medical Diet Plans and Human Growth Hormone (hGH) for Better Weight Loss Than Contrave
September 15, 2014 07:00 ET
|
Diet Doc Weight Loss
LOS ANGELES, Sept. 15, 2014 (GLOBE NEWSWIRE) -- The FDA recently approved Contrave, a weight loss drug being marketed for those who are obese and have, at least, one other accompanying illness....